共 4 条
[4]
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes[J] . J. Rosenstock,M. Davies,P. D. Home,J. Larsen,C. Koenen,G. Schernthaner.Diabetologia . 2008 (3)